Spotting latent infection: the path to better tuberculosis control

Lalvani A
November 2003
Thorax;Nov2003, Vol. 58 Issue 11, p916
Academic Journal
No abstract available.


Related Articles

  • CITATIONS AND CLINICIANS' NOTES: RESPIRATORY INFECTIONS.  // Current Medical Literature: Respiratory Medicine;2004, Vol. 18 Issue 1, p22 

    Presents citations and clinicians' notes on studies concerning respiratory infections. "Respiratory virus infections in the immunocompromised host," by A. Soldatou and E.G. Davies; "Respiratory viruses in the intensive care unit," by M. Roe, et al; "Spotting latent infection: the path to better...

  • Early Therapy for Latent Tuberculosis Infection. Ziv, Elad; Daley, Charles L.; Blower, Sally M. // American Journal of Epidemiology;Feb2001, Vol. 153 Issue 4, p381 

    The risk of developing active tuberculosis is highest within the first 2 years of infection. Therefore, an intervention that targets persons with recent infection, such as identifying contacts of active cases, could be particularly effective as an epidemic control measure. A mathematical model...

  • Detecting Latent Tuberculosis Infection Prior to Kidney Transplantation in a Tertiary Hospital in Saudi Arabia: Comparison of the T-SPOT.TB Test and Tuberculin Test. Hassan, Hoda Abdel Hadi; Shorman, Mahmoud; Housawi, Abdel Rahman E. I.; Elsammak, Mohamed Y. // British Microbiology Research Journal;Apr-Jun2013, Vol. 3 Issue 2, p116 

    Background: Tuberculosis (TB) remains a major worldwide public health problem with over 8.8 million newly diagnosed cases in 2010. Patients with end-stage renal disease (ESRD) who are on hemodialysis (HD) have a significantly higher incidence of Mycobacterium tuberculosis infection or disease...

  • Questions raised about TB blood tests.  // Hospital Employee Health;May2010, Vol. 29 Issue 5, p55 

    The article reports on the plans of the Centers for Disease Control and Prevention to release a new guideline for assessing the results of the interferongamma release assay, a blood test use to detect latent tuberculosis infection. Gerald Mazurek explains that people who are sensitized to the...

  • Identification and Management of Tuberculosis. Jerant, Anthony F.; Bannon, Michelle; Rittenhouse, Stephen // American Family Physician;5/1/2000, Vol. 61 Issue 9, p2667 

    Discusses about the identification and management of tuberculosis. Screening for tuberculosis; Treatment of latent tuberculosis infection; Prevention of nosocomial transmission.

  • UK immigrant screening is inversely related to regional tuberculosis burden. Pareek, Manish; Abubakar, Ibrahim; White, Peter J.; Garnett, Geoffrey P.; Lalvani, Ajit // Thorax;Nov2011, Vol. 66 Issue 11, p1010 

    A letter to the editor is presented in response to the article in the previous issue by Moore-Gillon that suggested a comprehensive system of immigrant screening/treatment for latent tuberculosis infection (LTBI) to augment tuberculosis (TB) control in the Great Britain.

  • Changing Concepts of "Latent Tuberculosis Infection" in Patients Living with HIV Infection. Lawn, Stephen D.; Wood, Robin; Wilkinson, Robert J. // Clinical & Developmental Immunology;2011, p1 

    One third of the world's population is estimated to be infected with Mycobacterium tuberculosis, representing a huge reservoir of potential tuberculosis (TB) disease. Risk of progression to active TB is highest in those with HIV coinfection. However, the nature of the host-pathogen relationship...

  • Human gene expression profiles of susceptibility and resistance in tuberculosis. Maertzdorf, J; Repsilber, D; Parida, S K; Stanley, K; Roberts, T; Black, G; Walzl, G; Kaufmann, S H E // Genes & Immunity;Jan2011, Vol. 12 Issue 1, p15 

    Tuberculosis (TB) still poses a profound burden on global health, owing to significant morbidity and mortality worldwide. Although a fully functional immune system is essential for the control of Mycobacterium tuberculosis infection, the underlying mechanisms and reasons for failure in part of...

  • Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection - United States, 2010. Mazurek, Gerald H.; Jereb, John; Vernon, Andrew; LoBue, Phillip; Goldberg, Stefan; Castro, Kenneth // MMWR Recommendations & Reports;6/25/2010, Vol. 59 Issue RR-5, p1 

    In 2005, CDC published guidelines for using the QuantiFERON-TB Gold test (QFT-G) (Cellestis Limited, Carnegie, Victoria, Australia) (CDC. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR;54[No. RR- 15]:49-55). Subsequently,...

  • Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection. Ahmad, Suhail // Clinical & Developmental Immunology;2011, p1 

    Phagocytosis of tubercle bacilli by antigen-presenting cells in human lung alveoli initiates a complex infection process by Mycobacterium tuberculosis and a potentially protective immune response by the host. M. tuberculosis has devoted a large part of its genome towards functions that allow it...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics